Related references
Note: Only part of the references are listed.The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model
Yusuke Nakatsu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds
Chengfu Xu et al.
JOURNAL OF HEPATOLOGY (2015)
Association between serum uric acid and nonalcoholic fatty liver disease in the US population
Ming-Hsiung Shih et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2015)
Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure
Sawsan A. Zaitone et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2015)
Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals
A. Cordeiro et al.
BIOMED RESEARCH INTERNATIONAL (2015)
PRMT3 Regulates Hepatic Lipogenesis Through Direct Interaction With LXR alpha
Dong-il Kim et al.
DIABETES (2015)
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease
Helena Gylling et al.
ATHEROSCLEROSIS (2014)
LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies
Rouyanne T. Ras et al.
BRITISH JOURNAL OF NUTRITION (2014)
Expression of Liver X Receptor Correlates with Intrahepatic Inflammation and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
Sang Bong Ahn et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis
Angela Provenzano et al.
LIVER INTERNATIONAL (2014)
TGFβ Receptor Signaling Is Essential for Inflammation-Induced but Not β-Cell Workload-Induced β-Cell Proliferation
Xiangwei Xiao et al.
DIABETES (2013)
Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1(Srebf1) and activation of peroxisome proliferator activated receptor alpha (Ppar alpha)
Li-juan Shi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Elovl6 Promotes Nonalcoholic Steatohepatitis
Takashi Matsuzaka et al.
HEPATOLOGY (2012)
The epidemiology, pathogenesis and histopathology of fatty liver disease
Adam P. Levene et al.
HISTOPATHOLOGY (2012)
Decorin-TGFβ Axis in Hepatic Fibrosis and Cirrhosis
Kornelia Baghy et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
High plasma uric acid concentration: causes and consequences
Erick Prado de Oliveira et al.
DIABETOLOGY & METABOLIC SYNDROME (2012)
Antidiabetic and antioxidant potential of β-sitosterol in streptozotocin-induced experimental hyperglycemia
Rajnish Gupta et al.
JOURNAL OF DIABETES (2011)
24-Epibrassinolide, a Phytosterol from the Brassinosteroid Family, Protects Dopaminergic Cells against MPP+ - Induced Oxidative Stress and Apoptosis
Julie Carange et al.
JOURNAL OF TOXICOLOGY (2011)
Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events
M. H. Ahmed et al.
DIABETES OBESITY & METABOLISM (2010)
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2010)
Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol
Kenichiro Yasutake et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis
Kristiaan Wouters et al.
HEPATOLOGY (2008)
Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
Hideyuki Hyogo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet
Naoto Matsuzawa et al.
HEPATOLOGY (2007)
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
Masato Yoneda et al.
JOURNAL OF GASTROENTEROLOGY (2007)
LXRβ is required for adipocyte growth, glucose homeostasis, and β cell function
I Gerin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue
BA Laffitte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease
ZP Li et al.
HEPATOLOGY (2003)
Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis
GQ Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Etiopathogenesis of nonalcoholic steatohepatitis
S Chitturi et al.
SEMINARS IN LIVER DISEASE (2001)
Share Paper
